Furthermore, mutations [52], posttranscriptional mechanisms [53], and posttranslational mechanisms [52, 54] are also involved in the dysregulation of BCL-2 family members in various haematopoietic cells and cancers. This evidence concerns the gene BCL2 and cancer.